|Status : Upcoming||Report Code : VRHC-1050||Industry : Healthcare||Available Format :|
Microbial identification is a method of accurate and conclusive detection of microorganisms, such as viruses, bacteria, and pathogen. It is broadly implemented in healthcare and management such as infection treatments and disease diagnosis. The global microbial identification market is growing at significant rate, due to mounting occurrence infectious diseases and technological improvement. Different product and services contributed to the microbial identification market size. The market has witnessed high demand for instruments in the coming years due to widespread usage of instruments.
Insight by Product and Services
On the basis of product and services the market is subdivided into instruments, services and consumables. Of all product and services, instruments segment is expected to grow at fastest rate in the market due to widespread usage of instruments and progresses in technology to advance inventive instruments. In addition, consumables segment accounted the largest share in the market, due to user friendly functioning principal of conventional microbial identification methods.
The instruments are further subdivided into automated microbial identification systems, PCR, microarrays, high-power microscopes, mass spectrometers, flow cytometer, polystainers and others. Moreover, the consumables are further subdivided into reagents & kits, plates & media and others. In addition, the services are further subdivided into culture collection services and identification services.
Insight by Method
On the basis of platform the market is subdivided into genotypic methods, phenotypic methods and proteomics-based methods. Cost-effectiveness, capability to deliver outcomes quickly, and easiness of usage which lead to amplified acceptance across different end users are some of the factors responsible for the growth of the phenotypic methods. Of all the platforms, the phenotypic methods accounted foremost share in the microbial identification market. In addition, genotypic method is expected to grow at fastest rate in the market.
Insight by Application
On the basis of application the market is subdivided into diagnostic and pharmaceutical applications, environmental applications, food and beverage testing, cosmetics and personal care products testing, and others. Safety concerns and budding mounting occurrence of infectious diseases are the factors growing the demand of diagnostic and pharmaceutical application. Among the all applications, the diagnostic and pharmaceutical application accounted the largest share in the microbial identification market.
Insight by End User
The different end users of the market are beverage manufacturing companies, pharmaceutical companies and contract research organization, hospitals, diagnostic laboratories, and blood banks, food manufacturing companies and others. Mounting occurrence of infectious diseases along with periodic outbreaks of epidemics and pandemics are the factors growing the demand of microbial identification in hospitals, diagnostic laboratories, and blood banks. Among the all end users, the hospitals, diagnostic laboratories, and blood banks accounted the largest share in the microbial identification market.
Mounting emphasis on maldi tof-based applications in identification and change from phenotypic to genotypic identification techniques are the trends in the microbial identification market.
Mounting occurrence of infectious diseases, escalating food safety concerns, government initiatives and funding for promoting microbial identification and technological improvement in microbial identification techniques are the primary growth drivers for microbial identification market. For instance, according to the World Health Organization (WHO), globally, in 2016 approximately 10.4 million people fell unwell with tuberculosis and approximately 1.7 million people die from the tuberculosis. Moreover, according to WHO in 2015 globally, approximately 887,000 deaths occurred due to complications of hepatitis B and in 2016 approximately one million people died from HIV related causes.
Initiatives to find and limit antimicrobial-resistant species, bioterrorism surveillance and mounting healthcare spending and refining healthcare infrastructure in developing economies are also facilitating the growth for the microbial identification market.
Elevated price of automated microbial identification systems and complicated regulatory frameworks are the major challenges for the growth of microbial identification market.
Globally, the manufacturing companies trying to enter the microbial identification market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.
Geographically, North America is the largest microbial identification market as in the region the acceptance of microbial techniques for research is increasing. Mounting occurrence of infectious diseases, safety concerns, budding occurrence of foodborne infections, and technological developments in microbial identification products are also up surging growth of the North American microbial identification market.
Asia-Pacific is observed to witness fastest growth in the market, due to budding need for microbial identification. In addition, mounting occurrence of infectious diseases, improving healthcare infrastructure and mounting healthcare expenditure are also creating a positive impact on the microbial identification market growth in the region.
Key players in the microbial identification market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In March 2018, Danaher Corporation signed an agreement to acquire Integrated DNA Technologies to expand its presence in genomic market. Becton, Dickinson and Company, Biomérieux S.A., Bruker Corporation, Thermo Fisher Scientific Inc., Shimadzu Corporation, Danaher Corporation, VWR Corporation, Merck KGaA, Eurofins Scientific S.E., Charles River Laboratories International, Inc. and Wickham Laboratories Ltd are the key players offering microbial identification.